About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
HALO - Halozyme Therapeutic...| Previous Close | $31.09 | Open | $31.13 |
| Volume | 1.18M | Market Cap | 4.26B |
| Yield | Last Dividend |
| $0.20 EPS Expected for Halozyme Therapeu... | 2:08 AM |
| Analysts expect that Halozyme Therapeutics, Inc. (NASDAQ:HALO) will announce $0.20 earnings per share (EPS) for the current quarter, according to Zack... | |
| The Daily Biotech Pulse: Gilead Gets Ful... | 10/23/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 22) Ami... | |
| Halozyme Therapeutics, Inc. (NASDAQ:HALO... | 10/23/20 |
| Halozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Michael J. Labarre sold 12,000 shares of the company???s stock in a transaction that occurred on Tuesday... | |
| Halozyme Therapeutics, Inc. (NASDAQ:HALO... | 10/22/20 |
| Wall Street analysts predict that Halozyme Therapeutics, Inc. (NASDAQ:HALO) will report $60.00 million in sales for the current fiscal quarter, accord... | |
| Halozyme To Host THIRD Quarter 2020 Fina... | 10/22/20 |
| SAN DIEGO, Oct. 22, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the third qu... | |
| Michael J. Labarre Sells 12,000 Shares o... | 10/21/20 |
| Halozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Michael J. Labarre sold 12,000 shares of Halozyme Therapeutics stock in a transaction that occurred on T... | |
| Brokerages Set Halozyme Therapeutics, In... | 10/21/20 |
| Halozyme Therapeutics, Inc. (NASDAQ:HALO) has received a consensus recommendation of ???Buy??? from the fourteen research firms that are currently cov... | |
| The Daily Biotech Pulse: Prothena Progre... | 10/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 20) Ail... | |
| Halozyme Therapeutics, Inc. (NASDAQ:HALO... | 10/20/20 |
| Halozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Michael J. Labarre sold 12,000 shares of Halozyme Therapeutics stock in a transaction on Tuesday, Octobe... | |
| Signal Says Biotech Stock Isn't Done Cli... | 10/20/20 |
| Halozyme Therapeutics stock's latest peak comes amid historically low implied volatility | |
| Halozyme Therapeutics (NASDAQ:HALO) Lift... | 10/19/20 |
| BidaskClub upgraded shares of Halozyme Therapeutics (NASDAQ:HALO) from a buy rating to a strong-buy rating in a report released on Saturday, BidAskClu... | |
| Halozyme Therapeutics (NASDAQ:HALO) Upgr... | 10/19/20 |
| BidaskClub upgraded shares of Halozyme Therapeutics (NASDAQ:HALO) from a buy rating to a strong-buy rating in a report released on Saturday morning, B... | |
| Halozyme Announces Expansion Of Collabor... | 10/06/20 |
| SAN DIEGO, Oct. 6, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Halozyme and argenx are expanding their existi... | |
| Halozyme Announces Poster Presentation O... | 09/17/20 |
| SAN DIEGO, Sept. 17, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that its collaborator, Roche, presented a poster ... | |
| Drug Stock May Be Overdue for a Short Sq... | 07/09/20 |
| Halozyme Therapeutics flashed a bull signal that could push the security to fresh record highs | |
| Why Is Halozyme Therapeutics (HALO) Up 1... | 06/10/20 |
| Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Will Halozyme Therapeutics Continue to S... | 05/08/20 |
| As of late, it has definitely been a great time to be an investor Halozyme Therapeutics | |
| Halozyme Therapeutics (HALO) Down 20.1% ... | 03/25/20 |
| Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| The Daily Biotech Pulse: Pfizer's Eczema... | 03/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)... | |
| Halozyme Announces FDA Has Accepted Biol... | 02/25/20 |
| SAN DIEGO, Feb. 25, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration has acc... | |
| Halozyme Announces CFO Transition | 02/24/20 |
| SAN DIEGO, Feb. 24, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine D. Sun has been appointed senior vice ... | |
| The Daily Biotech Pulse: FDA Approves Ba... | 02/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.... | |
| Halozyme To Host Fourth Quarter And Full... | 02/10/20 |
| SAN DIEGO, Feb. 10, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the fourth q... | |
| The Daily Biotech Pulse: Tonix Slumps On... | 02/06/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs F... | |
| The Daily Biotech Pulse: Novo Nordisk's ... | 01/17/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: Nektar Withdraw... | 01/15/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| Halozyme Provides 2020 Business Update A... | 01/14/20 |
| SAN DIEGO, Jan. 14, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today provided an update on its outlook for 2020, including financ... | |
| Halozyme Therapeutics To Present At The ... | 01/03/20 |
| SAN DIEGO, Jan. 3, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the 38th Annual J.P. Morgan Healthcare Confer... | |
| Why Is Halozyme Therapeutics (HALO) Up 6... | 12/12/19 |
| Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Data From Phase 3 Trial Evaluating Fixed... | 12/12/19 |
| /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that new data from the global phase III FeDeriCa study conducted by Genente... | |
| Date | 2020-08-10 (AMC) | Est. (EPS/Rev.) | $0.25/ 66.68M |
| Actual (EPS/Rev.) | $0.19/ $55.22 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Burdeshaw Investing | Matthew Burdeshaw | 55.00 % | Subscribe |
| Symmetry Options | Symmetry Options | 33.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
